Publications 2024

Slørdahl KS, Balto A, Guren MG, Wibe A, Kørner H, Norderval S, Gjelsvik YM, Myklebust TÅ, Larsen IK (2024)
Patient-reported outcomes after treatment for rectal cancer-A prospective nationwide study
Colorectal Dis (in press)
DOI 10.1111/codi.17231, PubMed 39515999

Publications 2023

Hanekamp BA, Viktil E, Slørdahl KS, Dormagen JB, Kløw NE, Malinen E, Brunborg C, Guren MG, Schulz A (2023)
Magnetic resonance imaging of anal cancer: tumor characteristics and early prediction of treatment outcome
Strahlenther Onkol, 200 (1), 19-27
DOI 10.1007/s00066-023-02114-5, PubMed 37429949

Publications 2021

Slørdahl KS, Klotz D, Olsen JÅ, Skovlund E, Undseth C, Abildgaard HL, Brændengen M, Nesbakken A, Larsen SG, Hanekamp BA, Holmboe L, Tvedt R, Sveen A, Lothe RA, Malinen E, Kaasa S, Guren MG (2021)
Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer
Acta Oncol, 60 (7), 921-930
DOI 10.1080/0284186X.2021.1918763, PubMed 33966592

Publications 2006

Gustafsson BI, Thommesen L, Stunes AK, Tommeras K, Westbroek I, Waldum HL, Slørdahl K, Tamburstuen MV, Reseland JE, Syversen U (2006)
Serotonin and fluoxetine modulate bone cell function in vitro
J Cell Biochem, 98 (1), 139-51
DOI 10.1002/jcb.20734, PubMed 16408289

Publications 2001

Kleveland O, Syversen U, Slørdahl K, Waldum HL (2001)
Hypergastrinemia as a cause of chromogranin a increase in blood in patients suspected to have neuroendocrine tumor
Digestion, 64 (2), 71-4
DOI 10.1159/000048842, PubMed 11684818